{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T15:13:15Z","timestamp":1793718795305,"version":"4.6.1"},"reference-count":71,"publisher":"American Medical Association (AMA)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Neurol"],"published-print":{"date-parts":[[2021,12,1]]},"DOI":"10.1001\/jamaneurol.2021.3416","type":"journal-article","created":{"date-parts":[[2021,10,5]],"date-time":"2021-10-05T02:11:11Z","timestamp":1633399871000},"page":"1515","source":"Crossref","is-referenced-by-count":170,"title":["Health Disparities, Inequities, and Social Determinants of Health in Multiple Sclerosis and Related Disorders in the US"],"prefix":"10.1001","volume":"78","author":[{"given":"Lilyana","family":"Amezcua","sequence":"first","affiliation":[{"name":"Keck School of Medicine, Department of Neurology, University of Southern California, Los Angeles"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor M.","family":"Rivera","sequence":"additional","affiliation":[{"name":"Department of Neurology, Baylor College of Medicine, Houston, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa Corona","family":"Vazquez","sequence":"additional","affiliation":[{"name":"National Institute of Neurology and Neurosurgery, Mexico City, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lourdes","family":"Baezconde-Garbanati","sequence":"additional","affiliation":[{"name":"Keck School of Medicine, Department of Preventive Medicine, Institute for Health Promotion and Disease Prevention, Norris Comprehensive Cancer Center, University of Southern California, Los Angeles"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annette","family":"Langer-Gould","sequence":"additional","affiliation":[{"name":"Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"2","key":"nrv210006r1","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/s41582-020-00452-x","article-title":"Inequities in neurology amplified by the COVID-19 pandemic.","volume":"17","author":"Nolen","year":"2021","journal-title":"Nat Rev Neurol"},{"issue":"16","key":"nrv210006r2","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1001\/jama.2016.14058","article-title":"Addressing social determinants of health and health inequalities.","volume":"316","author":"Adler","year":"2016","journal-title":"JAMA"},{"issue":"21","key":"nrv210006r3","doi-asserted-by":"publisher","first-page":"1970","DOI":"10.3109\/09638288.2014.993435","article-title":"Demographic, socioeconomic and clinical correlates of self-management in multiple sclerosis.","volume":"37","author":"Wilski","year":"2015","journal-title":"Disabil Rehabil"},{"issue":"10077","key":"nrv210006r5","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1016\/S0140-6736(17)30569-X","article-title":"Structural racism and health inequities in the USA: evidence and interventions.","volume":"389","author":"Bailey","year":"2017","journal-title":"Lancet"},{"issue":"5","key":"nrv210006r6","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1002\/ana.24617","article-title":"Epidemiology of aquaporin-4 autoimmunity and neuromyelitis optica spectrum.","volume":"79","author":"Flanagan","year":"2016","journal-title":"Ann Neurol"},{"issue":"19","key":"nrv210006r7","doi-asserted-by":"publisher","first-page":"1734","DOI":"10.1212\/WNL.0b013e3182918cc2","article-title":"Incidence of multiple sclerosis in multiple racial and ethnic groups.","volume":"80","author":"Langer-Gould","year":"2013","journal-title":"Neurology"},{"issue":"10","key":"nrv210006r8","doi-asserted-by":"publisher","first-page":"2088","DOI":"10.1007\/s00415-017-8596-7","article-title":"What proportion of AQP4-IgG-negative NMO spectrum disorder patients are MOG-IgG positive? a cross sectional study of 132 patients.","volume":"264","author":"Hamid","year":"2017","journal-title":"J Neurol"},{"issue":"3-4","key":"nrv210006r9","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1159\/000484090","article-title":"Increasing incidence and prevalence of multiple sclerosis in Puerto Rico (2013-2016).","volume":"49","author":"Chinea","year":"2017","journal-title":"Neuroepidemiology"},{"issue":"11","key":"nrv210006r10","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.1177\/1352458516679894","article-title":"Hispanic Americans and African Americans with multiple sclerosis have more severe disease course than Caucasian Americans.","volume":"23","author":"Ventura","year":"2017","journal-title":"Mult Scler"},{"issue":"3","key":"nrv210006r11","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000225","article-title":"Neuromyelitis optica spectrum disorders: comparison according to the phenotype and serostatus.","volume":"3","author":"Sep\u00falveda","year":"2016","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"7","key":"nrv210006r12","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1177\/1756285617709723","article-title":"Differential diagnosis of neuromyelitis optica spectrum disorders.","volume":"10","author":"Kim","year":"2017","journal-title":"Ther Adv Neurol Disord"},{"issue":"5","key":"nrv210006r13","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000583","article-title":"Collaborative international research in clinical and longitudinal experience study in NMOSD.","volume":"6","author":"Cook","year":"2019","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"2","key":"nrv210006r14","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1038\/s41582-018-0112-x","article-title":"Myelin oligodendrocyte glycoprotein antibodies in neurological disease.","volume":"15","author":"Reindl","year":"2019","journal-title":"Nat Rev Neurol"},{"issue":"8","key":"nrv210006r15","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1177\/1352458511403025","article-title":"Multiple sclerosis in Hispanics: a study of clinical disease expression.","volume":"17","author":"Amezcua","year":"2011","journal-title":"Mult Scler"},{"issue":"21","key":"nrv210006r16","doi-asserted-by":"publisher","first-page":"e1858","DOI":"10.1212\/WNL.0000000000005560","article-title":"Clinical spectrum and prognostic value of CNS MOG autoimmunity in adults: the MOGADOR study.","volume":"90","author":"Cobo-Calvo","year":"2018","journal-title":"Neurology"},{"issue":"18","key":"nrv210006r17","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.1212\/WNL.0000000000002090","article-title":"Availability, accessibility, and affordability of neurodiagnostic tests in 37 countries.","volume":"85","author":"McLane","year":"2015","journal-title":"Neurology"},{"issue":"Pt 6","key":"nrv210006r18","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1093\/brain\/aws099","article-title":"The Gulf War era multiple sclerosis cohort: age and incidence rates by race, sex and service.","volume":"135","author":"Wallin","year":"2012","journal-title":"Brain"},{"issue":"10","key":"nrv210006r19","doi-asserted-by":"publisher","first-page":"e1029","DOI":"10.1212\/WNL.0000000000007035","article-title":"The prevalence of MS in the United States: a population-based estimate using health claims data.","volume":"92","author":"Wallin","year":"2019","journal-title":"Neurology"},{"issue":"9","key":"nrv210006r20","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1001\/archneurol.2012.314","article-title":"Epidemiology of neuromyelitis optica in the United States: a multicenter analysis.","volume":"69","author":"Mealy","year":"2012","journal-title":"Arch Neurol"},{"issue":"2","key":"nrv210006r21","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1002\/ana.24554","article-title":"Neuromyelitis optica: evaluation of 871 attacks and 1,153 treatment courses.","volume":"79","author":"Kleiter","year":"2016","journal-title":"Ann Neurol"},{"issue":"1","key":"nrv210006r22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00415-013-7169-7","article-title":"Update on the diagnosis and treatment of neuromyelitis optica: recommendations of the Neuromyelitis Optica Study Group (NEMOS).","volume":"261","author":"Trebst","year":"2014","journal-title":"J Neurol"},{"issue":"5","key":"nrv210006r23","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1177\/1352458519887328","article-title":"Race and ethnicity on MS presentation and disease course.","volume":"26","author":"Amezcua","year":"2020","journal-title":"Mult Scler"},{"issue":"1-2","key":"nrv210006r24","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1159\/000484213","article-title":"Multiple sclerosis mortality by race\/ethnicity, age, sex, and time period in the United States, 1999-2015.","volume":"50","author":"Amezcua","year":"2018","journal-title":"Neuroepidemiology"},{"issue":"4","key":"nrv210006r25","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1159\/000431375","article-title":"Clinical expression of multiple sclerosis in Hispanic Whites of primarily Caribbean ancestry.","volume":"44","author":"Hadjixenofontos","year":"2015","journal-title":"Neuroepidemiology"},{"issue":"8","key":"nrv210006r26","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1097\/01.PHM.0000078199.99484.E2","article-title":"Multiple sclerosis: severity and progression rate in African Americans compared with Whites.","volume":"82","author":"Kaufman","year":"2003","journal-title":"Am J Phys Med Rehabil"},{"issue":"4","key":"nrv210006r27","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000468","article-title":"Mortality in neuromyelitis optica is strongly associated with African ancestry.","volume":"5","author":"Mealy","year":"2018","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"22","key":"nrv210006r28","doi-asserted-by":"publisher","first-page":"e2089","DOI":"10.1212\/WNL.0000000000006574","article-title":"Racial differences in neuromyelitis optica spectrum disorder.","volume":"91","author":"Kim","year":"2018","journal-title":"Neurology"},{"issue":"5","key":"nrv210006r29","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1093\/brain\/awz054","article-title":"Outcome prediction models in AQP4-IgG positive neuromyelitis optica spectrum disorders.","volume":"142","author":"Palace","year":"2019","journal-title":"Brain"},{"issue":"12","key":"nrv210006r30","doi-asserted-by":"publisher","first-page":"3128","DOI":"10.1093\/brain\/awx276","article-title":"Clinical presentation and prognosis in MOG-antibody disease: a UK study.","volume":"140","author":"Jurynczyk","year":"2017","journal-title":"Brain"},{"issue":"1","key":"nrv210006r31","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1001\/jamaneurol.2019.2940","article-title":"Serial anti-myelin oligodendrocyte glycoprotein antibody analyses and outcomes in children with demyelinating syndromes.","volume":"77","author":"Waters","year":"2020","journal-title":"JAMA Neurol"},{"key":"nrv210006r32","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.msard.2019.05.013","article-title":"Neuromyelitis optica testing and treatment: availability and affordability in 60 countries.","volume":"33","author":"Holroyd","year":"2019","journal-title":"Mult Scler Relat Disord"},{"issue":"4","key":"nrv210006r33","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000580","article-title":"Neuromyelitis optica spectrum disorder: patient experience and quality of life.","volume":"6","author":"Beekman","year":"2019","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"1","key":"nrv210006r34","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1111\/hex.2017.20.issue-1","article-title":"Development of a patient-centred conceptual framework of health-related quality of life in neuromyelitis optica: a qualitative study.","volume":"20","author":"Methley","year":"2017","journal-title":"Health Expect"},{"issue":"24","key":"nrv210006r35","doi-asserted-by":"publisher","first-page":"2268","DOI":"10.1212\/WNL.0000000000004025","article-title":"Racial disparities in neurologic health care access and utilization in the United States.","volume":"88","author":"Saadi","year":"2017","journal-title":"Neurology"},{"key":"nrv210006r36","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.jns.2017.11.022","article-title":"Evaluation of comorbidities and health care resource use among patients with highly active neuromyelitis optica.","volume":"384","author":"Ajmera","year":"2018","journal-title":"J Neurol Sci"},{"issue":"1","key":"nrv210006r37","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1186\/s12913-018-3584-x","article-title":"Racial disparities in Medicaid home and community-based service utilization and expenditures among persons with multiple sclerosis.","volume":"18","author":"Fabius","year":"2018","journal-title":"BMC Health Serv Res"},{"key":"nrv210006r38","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2020.102220","article-title":"Neuropsychological assessments and psychotherapeutic services in Veterans with multiple sclerosis: rates of utilization and their associations with socio-demographics and clinical characteristics using Veterans Health Administration-based data.","volume":"43","author":"Gromisch","year":"2020","journal-title":"Mult Scler Relat Disord"},{"issue":"8","key":"nrv210006r39","first-page":"935","article-title":"Unfilled prescriptions of Medicare beneficiaries: prevalence, reasons, and types of medicines prescribed.","volume":"26","author":"Kennedy","year":"2020","journal-title":"J Manag Care Spec Pharm"},{"issue":"1","key":"nrv210006r40","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1080\/03007995.2017.1374937","article-title":"Adherence, persistence, and discontinuation among Hispanic and African American patients with multiple sclerosis treated with fingolimod or glatiramer acetate.","volume":"34","author":"Williams","year":"2018","journal-title":"Curr Med Res Opin"},{"issue":"1","key":"nrv210006r41","doi-asserted-by":"crossref","DOI":"10.2196\/ijmr.2993","article-title":"Health literacy association with health behaviors and health care utilization in multiple sclerosis: a cross-sectional study.","volume":"3","author":"Marrie","year":"2014","journal-title":"Interact J Med Res"},{"issue":"14","key":"nrv210006r42","doi-asserted-by":"publisher","first-page":"e1548","DOI":"10.1212\/WNL.0000000000009210","article-title":"Race, ethnicity, and cognition in persons newly diagnosed with multiple sclerosis.","volume":"94","author":"Amezcua","year":"2020","journal-title":"Neurology"},{"key":"nrv210006r43","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2020.102010","article-title":"Socioeconomic status and race are correlated with affective symptoms in multiple sclerosis.","volume":"41","author":"Wang","year":"2020","journal-title":"Mult Scler Relat Disord"},{"issue":"3","key":"nrv210006r44","doi-asserted-by":"publisher","first-page":"131","DOI":"10.7224\/1537-2073.2015-081","article-title":"Perceptions of multiple sclerosis in Hispanic Americans: need for targeted messaging.","volume":"19","author":"Obiwuru","year":"2017","journal-title":"Int J MS Care"},{"key":"nrv210006r45","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s12904-015-0017-z","article-title":"Exploring meanings of illness causation among those severely affected by multiple sclerosis: a comparative qualitative study of Black Caribbean and White British people.","volume":"14","author":"Koffman","year":"2015","journal-title":"BMC Palliat Care"},{"issue":"2","key":"nrv210006r46","doi-asserted-by":"publisher","first-page":"59","DOI":"10.7224\/1537-2073.2019-068","article-title":"Experiences of African American women with multiple sclerosis.","volume":"23","author":"Stuifbergen","year":"2021","journal-title":"Int J MS Care"},{"issue":"4","key":"nrv210006r47","doi-asserted-by":"publisher","first-page":"170","DOI":"10.7224\/1537-2073.2019-131","article-title":"Perceptions and preferences regarding multiple sclerosis research among racial and ethnic groups.","volume":"23","author":"Pimentel Maldonado","year":"2021","journal-title":"Int J MS Care"},{"issue":"1","key":"nrv210006r48","article-title":"Effectiveness of film as a health communication tool to improve perceptions and attitudes in multiple sclerosis.","volume":"7","author":"Chiong-Rivero","year":"2021","journal-title":"Mult Scler J Exp Transl Clin"},{"issue":"5","key":"nrv210006r49","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1111\/ane.2016.133.issue-5","article-title":"Illness perception, treatment beliefs, self-esteem, and self-efficacy as correlates of self-management in multiple sclerosis.","volume":"133","author":"Wilski","year":"2016","journal-title":"Acta Neurol Scand"},{"issue":"1","key":"nrv210006r50","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s10880-015-9425-8","article-title":"Illness perception and well-being among persons with multiple sclerosis and their caregivers.","volume":"23","author":"Bassi","year":"2016","journal-title":"J Clin Psychol Med Settings"},{"issue":"6","key":"nrv210006r51","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1191\/1352458505ms1215oa","article-title":"Multiple sclerosis management for low-income minorities.","volume":"11","author":"Shabas","year":"2005","journal-title":"Mult Scler"},{"issue":"2","key":"nrv210006r52","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1080\/10410236.2014.974126","article-title":"Telling stories, saving lives: creating narrative health messages.","volume":"30","author":"Frank","year":"2015","journal-title":"Health Commun"},{"issue":"11","key":"nrv210006r53","doi-asserted-by":"crossref","DOI":"10.1002\/brb3.1842","article-title":"Cognitive impairment in NMOSD\u2014more questions than answers.","volume":"10","author":"Czarnecka","year":"2020","journal-title":"Brain Behav"},{"issue":"11","key":"nrv210006r54","doi-asserted-by":"publisher","first-page":"3433","DOI":"10.1161\/STROKEAHA.120.030426","article-title":"Considerations in addressing social determinants of health to reduce racial\/ethnic disparities in stroke outcomes in the United States.","volume":"51","author":"Skolarus","year":"2020","journal-title":"Stroke"},{"issue":"2","key":"nrv210006r55","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1212\/CPJ.0000000000000112","article-title":"Multiple sclerosis in US minority populations: Clinical practice insights.","volume":"5","author":"Khan","year":"2015","journal-title":"Neurol Clin Pract"},{"key":"nrv210006r56","article-title":"Multiple sclerosis treatment in racial and ethnic minorities.","author":"Robers","year":"2020","journal-title":"Pract Neurol"},{"issue":"11","key":"nrv210006r57","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1002\/acn3.2018.5.issue-11","article-title":"Native ancestry is associated with optic neuritis and age of onset in Hispanics with multiple sclerosis.","volume":"5","author":"Amezcua","year":"2018","journal-title":"Ann Clin Transl Neurol"},{"issue":"11","key":"nrv210006r58","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1177\/1352458519863764","article-title":"The genetic diversity of multiple sclerosis risk among Hispanic and African American populations living in the United States.","volume":"26","author":"Beecham","year":"2020","journal-title":"Mult Scler"},{"issue":"1","key":"nrv210006r59","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1007808","article-title":"Admixture mapping reveals evidence of differential multiple sclerosis risk by genetic ancestry.","volume":"15","author":"Chi","year":"2019","journal-title":"PLoS Genet"},{"issue":"1","key":"nrv210006r60","doi-asserted-by":"publisher","first-page":"4","DOI":"10.2174\/1871524916666160229115047","article-title":"Neuromyelitis optica (NMO IgG+) and genetic susceptibility, potential ethnic influences.","volume":"18","author":"Alonso","year":"2018","journal-title":"Cent Nerv Syst Agents Med Chem"},{"issue":"10077","key":"nrv210006r62","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1016\/S0140-6736(17)30786-9","article-title":"The Affordable Care Act: implications for health-care equity.","volume":"389","author":"Gaffney","year":"2017","journal-title":"Lancet"},{"issue":"12","key":"nrv210006r63","doi-asserted-by":"publisher","first-page":"e60","DOI":"10.2105\/AJPH.2015.302903","article-title":"Implicit racial\/ethnic bias among health care professionals and its influence on health care outcomes: a systematic review.","volume":"105","author":"Hall","year":"2015","journal-title":"Am J Public Health"},{"issue":"3","key":"nrv210006r64","doi-asserted-by":"publisher","first-page":"216","DOI":"10.3988\/jcn.2014.10.3.216","article-title":"Emergency medical care of multiple sclerosis patients: primary data from the Mount Sinai Resource Utilization in Multiple Sclerosis Project.","volume":"10","author":"Oynhausen","year":"2014","journal-title":"J Clin Neurol"},{"issue":"22","key":"nrv210006r65","doi-asserted-by":"publisher","first-page":"e2604","DOI":"10.1212\/WNL.0000000000007564","article-title":"Out-of-pocket costs are on the rise for commonly prescribed neurologic medications.","volume":"92","author":"Callaghan","year":"2019","journal-title":"Neurology"},{"issue":"11","key":"nrv210006r66","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1001\/jamaneurol.2019.2711","article-title":"Trends in prices, market share, and spending on self-administered disease-modifying therapies for multiple sclerosis in Medicare part D.","volume":"76","author":"San-Juan-Rodriguez","year":"2019","journal-title":"JAMA Neurol"},{"issue":"7","key":"nrv210006r67","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0159129","article-title":"Cost of illness of multiple sclerosis\u2014a systematic review.","volume":"11","author":"Ernstsson","year":"2016","journal-title":"PLoS One"},{"issue":"5","key":"nrv210006r68","doi-asserted-by":"publisher","first-page":"74","DOI":"10.3390\/socsci7050074","article-title":"Diminished economic return of socioeconomic status for Black families.","volume":"7","author":"Assari","year":"2018","journal-title":"Soc Sci (Basel)"},{"issue":"8","key":"nrv210006r69","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.2105\/AJPH.2010.300086","article-title":"Estimated deaths attributable to social factors in the United States.","volume":"101","author":"Galea","year":"2011","journal-title":"Am J Public Health"},{"issue":"3","key":"nrv210006r70","doi-asserted-by":"publisher","first-page":"245","DOI":"10.18865\/ed.25.3.245","article-title":"The National Institute on Aging Health Disparities Research Framework.","volume":"25","author":"Hill","year":"2015","journal-title":"Ethn Dis"},{"issue":"1","key":"nrv210006r71","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1056\/NEJMp1512532","article-title":"Accountable health communities\u2014addressing social needs through Medicare and Medicaid.","volume":"374","author":"Alley","year":"2016","journal-title":"N Engl J Med"},{"key":"nrv210006r4","volume-title":"Tackling health inequities through public health practice: theory to action","author":"Hofrichter","year":"2010","edition":"2nd Edition"},{"key":"nrv210006r61","unstructured":"US Department of Heath and Human Services. Healthy People 2030. Accessed August 31, 2021. https:\/\/www.healthypeople.gov\/2020\/"}],"container-title":["JAMA Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamaneurology\/articlepdf\/2784442\/jamaneurology_amezcua_2021_rv_210006_1638811654.13613.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,9]],"date-time":"2021-12-09T16:22:04Z","timestamp":1639066924000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamaneurology\/fullarticle\/2784442"}},"subtitle":["A Review"],"short-title":[],"issued":{"date-parts":[[2021,12,1]]},"references-count":71,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2021,12,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaneurol.2021.3416","relation":{},"ISSN":["2168-6149"],"issn-type":[{"value":"2168-6149","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12,1]]}}}